Health Condition 1: I259- Chronic ischemic heart disease, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: NIL: NIL
Sponsors
Anil Neerukonda Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients who have been treated with a Sirolimus- or Everolimus-Eluting Coronary Stent System and have completed a minimum of 1-year follow-up. Participants who are willing to comply with study-related follow-up requirements.
Exclusion criteria
Exclusion criteria: Patients who have not been treated with a Sirolimus- or Everolimus-Eluting Coronary Stent System or have not completed a minimum of 1-year follow-up. Participants who are unwilling to comply with study-related follow-up requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Major Adverse Cardiac Events 2. Target Lesion FailureTimepoint: 1. Time Frame: Baseline, post-procedure, Through 1 year, 6 month ± 15 days 2. Time Frame: Baseline, post-procedure, Through 1 year, 6 month ± 15 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Target vessel failure 2. Quality of Life (QoL) questionnaire 3. All mortality rate 4. Non-Cardiac adverse events 5. Device and procedural SuccessTimepoint: 1. Time Frame: Baseline, post-procedure, Through 1 year, 6 month ± 15 days 2. Time Frame: through 1 year, 6 month ± 15 days 3. Time Frame: Baseline, post-procedure, Through 1 year, 6 month ± 15 days 4. Time Frame: Baseline, post-procedure, Through 1 year, 6 month ± 15 days 5. Time Frame:Intra- Operative, Post-Procedure | — |
Countries
India
Contacts
Public ContactDr Suresh Kumar Paidi
Rajju Shroff Rofel university
Outcome results
None listed